Erlotinib Hydrochloride
Generic Name: erlotinib hydrochloride
Brand Names:
Erlotinib Hydrochloride
Erlotinib hydrochloride is a prescription kinase inhibitor (quinazolinamine) available as tablets in 25 mg, 100 mg, and 150 mg strengths for the treatment of certain cancers.
Overview
Erlotinib hydrochloride is a prescription kinase inhibitor (quinazolinamine) available as tablets in 25 mg, 100 mg, and 150 mg strengths for the treatment of certain cancers.
Uses
Treatment of metastatic non-small cell lung cancer (NSCLC) with specific EGFR mutations and first-line treatment of locally advanced, unresectable or metastatic pancreatic cancer.
Dosage
150 mg orally, on an empty stomach, once daily for NSCLC. 100 mg orally, on an empty stomach, once daily for pancreatic cancer combined with gemcitabine.
Side Effects
Most common include rash, diarrhea, fatigue, anorexia, dyspnea, cough, nausea, and vomiting.
Interactions
CYP3A4 inhibitors, inducers, smoking, and gastric pH-altering agents significantly affect erlotinib levels.
Warnings
Includes interstitial lung disease, renal failure, hepatotoxicity, gastrointestinal perforation, skin disorders, and ocular disorders.
Pregnancy
Can cause fetal harm. Advise females to use contraception during and one month after treatment.
Frequently Asked Questions
What is Erlotinib Hydrochloride used for?▼
Treatment of metastatic non-small cell lung cancer (NSCLC) with specific EGFR mutations and first-line treatment of locally advanced, unresectable or metastatic pancreatic cancer.
What are the side effects of Erlotinib Hydrochloride?▼
Most common include rash, diarrhea, fatigue, anorexia, dyspnea, cough, nausea, and vomiting.
Can I take Erlotinib Hydrochloride during pregnancy?▼
Can cause fetal harm. Advise females to use contraception during and one month after treatment.
What are the important warnings for Erlotinib Hydrochloride?▼
Includes interstitial lung disease, renal failure, hepatotoxicity, gastrointestinal perforation, skin disorders, and ocular disorders.
Related Medications
Mycophenolate Mofetil Hydrochloride Anhydrous
mycophenolate mofetil hydrochloride anhydrous
Dosage form: POWDER. Active ingredients: MYCOPHENOLATE MOFETIL HYDROCHLORIDE (50 kg/50kg). Category: BULK INGREDIENT.
Meradimate, Octinoxate, Oxybenzone, And Zinc Oxide
meradimate, octinoxate, oxybenzone, and zinc oxide
Purpose Sunscreen
Sodium Sulfacetamide
sodium sulfacetamide
Description Each gram contains 100 mg of sodium sulfacetamide in a vehicle consisting of: Butylated Hydroxytoluene, Citric Acid, Cetyl Alcohol, Cocamidopropyl Betaine, Disodium EDTA, Glycerin, Glyceryl Stearate SE, PEG-100 Stearate, Phenoxyethanol, Purified Water, Sodium Laureth Sulfate, Sodium Thiosulfate, Stearyl Alcohol, Triacetin, Xanthan Gum.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.